Contents
Article 3Requirements for granting disease-free status for category A diseases to compartments keeping terrestrial animals#
1.Operators that apply to the competent authority for approval of the disease-free status for a category A disease of a compartment keeping terrestrial animals shall ensure that:
(a)the surveillance in the compartment for the category A disease complies with:
(i)the requirements on the design of surveillance laid down in Article 3(1) of Delegated Regulation (EU) 2020/689;
(ii)the specific surveillance requirements laid down in Chapter III of this Regulation;
(b)the biosecurity measures in place in the compartment comply with:
(i)the requirements laid down in Article 10 of Regulation (EU) 2016/429;
(ii)the specific biosecurity requirements laid down in Chapter III of this Regulation;
(c)establishments forming part of the compartment:
(i)are approved in accordance with Article 94(1), points (b) to (e), of Regulation (EU) 2016/429; and
(ii)comply with Article 97(1) of Regulation (EU) 2016/429;
(d)establishments forming part of the compartment are not:
(i)establishments keeping:
—free-range animals;
—more than one animal species in the same epidemiological unit;
(ii)establishments for assembly operations, markets, exhibition places, fairs, animal shelters, confined establishments, zoos, and wildlife sanctuaries.
2.Operators that apply to the competent authority for approval of the disease-free status for a category A disease of a compartment keeping terrestrial animals shall appoint an appropriately qualified compartment manager who shall ensure:
(a)compliance with the requirements set out in Part I of Annex I;
(b)that all establishments forming part of the compartment, as well as all other compartment components, are managed under a common biosecurity management system, which complies with the requirements set out in Part II of Annex I;
(c)that all involved parties comply with the requirements of the common biosecurity management system.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.